SCHEMBL21754310

SCHEMBL21754310

Cc1cnn2c(-c3cncc(F)c3)cc(O)nc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT1 P42224 2/20 0.36
CYP11B2 P19099 7/20 0.36
CYP11B1 P15538 6/20 0.36
CYP17A1 P05093 2/20 0.33
CYP3A4 P08684 1/20 0.33
TLR7 Q9NYK1 4/20 0.33
NPC1 O15118 5/20 0.33
RAB9A P51151 5/20 0.33
SMN1; SMN2 Q16637 5/20 0.33
MAPT P10636 4/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP19A1 P11511 2/20 0.32
ADRA2B P18089 1/20 0.32
CHRNB2 P17787 1/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA7 P36544 1/20 0.32
CHRNA4 P43681 1/20 0.32
ALDH1A1 P00352 2/20 0.31
KDM4E B2RXH2 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30579311 0.84 STAT1 (0.36) STAT1CYP11B2CYP11B1CYP17A1CYP3A4
SCHEMBL20558144 0.84 STAT1 (0.36) STAT1CYP11B2CYP11B1CYP17A1CYP3A4
SCHEMBL20542249 0.78 CYP11B2 (0.36) CYP11B2CYP11B1CYP17A1CYP3A4TLR7
SCHEMBL30579302 0.78 ALDH1A1 (0.37) CYP11B2CYP11B1CYP17A1CYP3A4TLR7
SCHEMBL20558056 0.78 ALDH1A1 (0.37) CYP11B2CYP11B1CYP17A1CYP3A4TLR7
SCHEMBL30579319 0.78 CYP11B2 (0.36) CYP11B2CYP11B1CYP17A1CYP3A4TLR7
SCHEMBL20541863 0.77 CYP11B2 (0.40) CYP11B2CYP11B1CYP17A1CYP3A4TLR7
SCHEMBL30579378 0.77 CYP11B2 (0.40) CYP11B2CYP11B1CYP17A1CYP3A4TLR7
SCHEMBL20542195 0.73 KDM4E (0.37) CYP11B2CYP11B1CYP17A1CYP3A4TLR7
SCHEMBL20542084 0.73 CYP11B2 (0.36) CYP11B2CYP11B1CYP17A1CYP3A4TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10570138-B2 Indole AHR inhibitors and uses thereof KYN THERAPEUTICS (US) 2020-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10570138-B2 Indole AHR inhibitors and uses thereof AHR, ARNT, IDO1 STAT1 1152/4885CYP11B2 86/4885CYP11B1 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.